Hernando BG, Bernárdez ZI, Iglesias LJ, Patiño BEJ, Rendón MME

Language: Spanish
References: 14
Page: 131-135
PDF size: 124.07 Kb.

ABSTRACT

The management of patent ductus arteriosus is still controversial in premature newborns.
Objective: To analyze the therapeutic conduct used for the closure of patent ductus arteriosus in premature newborns ≤ 30 weeks of gestation.
Methods: A retrospective analysis (2005-2011) we analyzed the clinical and morfophysiologic aspects of the ductus with the treatment used.
Results: 66 patients, 49 (74.2%) were asymptomatic and required only conservative treated, 16 (24.3%) received pharmacologic treatment (Ibuprofen and/or indomethacin) and only one received surgical ligation as primary option. Six of those who received pharmacological treatment required ductal ligation afterwards (9.1%) (all symptomatic). The symptomatic patients had larger ducts with more flow and pulmonary arterial hypertension. There were no complications associated with the surgical ligation.
Conclusion: The conservative treatment in those patients that were asymptomatic is the best option, however in symptomatic patients, even though the closure was 100% effective with pharmacologic treatment or surgical ligation, the decision is not influenced by the morphophysiology characteristics of the duct.

REFERENCES

1. Sekar KC. Protective strategies to prevent patent ductus arteriosus. Chin Med J (English edition). 2010; 123(20): 2914-2918.

2. Fagionato LR, Antique GE, Bertini (Jr) A, La Rota CA, Catani RE. Patent ductus arteriosus treatment in the premature newborn: clinical and surgical analysis. Arq Bras Cardiol. 2008; 90(5): 316-319.

3. V Congreso de SIBEN Mar de Plata-Argentina. Ductus Arterioso Permeable en Recién nacidos de pretérmino. En: Resumen del Primer Consenso Clínico de la Sociedad Iberoamericana de Neonatología, 2008.

4. Ruiz GMD, Gómez GE, Párraga QM, Tejero MA, Guzmán CJM. Ductus arterioso persistente. Protocolos diagnóstico terapéuticos de la AEP. Neonatología. 2008; 36: 353-361.

5. Schneider DJ, Moore JW, Patent ductus arteriosus. Circulation. 2006; 114(17): 1873-1882.

6. Sasi A, Deorari A. Patent ductus arteriosus in preterm infants. Ind Ped. 2011; 48(4): 301-308.

7. Antonucci R, Bassareo P, Zaffanello M, Pusceddu M, Fanos V. Patent ductus arteriosus in the preterm infant: new insights into pathogenesis and clinical management. J Matern Fetal Neonatal Med. 2010; 23 (Suppl 3): 34-37.

8. Gallardo-Meza AF, González-Sanchez JM, Piña-Garay MA y cols. Experiencia en el cierre quirúrgico de ducto arterioso permeable en una Unidad de Cuidados Intensivos Neonatales (UCIN) de un Hospital de Segundo Nivel, en Guadalajara, Jal. México. Rev Mex Cir Ped. 2010; 17(1): 19-23.

9. Vanhaesebrouck S, Zonnenberg I, Vandervoort P, Bruneel E, Van Hoesternberghe MR, Theyskens C. Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed. 2007; 92(4): F244- F247.

10. Bose CL, Laughon MM. Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed. 2007; 92(6): F498-502.

11. Hamrick, SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics. 2010; 125(5): 1020-1030.

12. Kluckow M, Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr. 1995; 127(5): 774-779.

13. Gokmen T, Erdeve O, Altug N, Suna-Oguz S, Urs N, Dilmen U. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr. 2011; 158(4): 549-554 e1.

14. Lemmers PMA, Molenschot MC, Evens J, Toet MC, Van Bel F. Is cerebral oxygen supply compromised in preterm infants undergoing surgical closure for patent ductus arteriosus? Arch Dis Child Fetal Neonatal Ed. 2009; 95: F429-F434.